The present disclosure provides systems and methods for disrupting the outer membrane of an oocyst in solution and delivering the solution to an animal. The system includes a vessel containing unbroken oocysts in solution, an oocyst processing chamber, and a delivery outlet. The unbroken oocysts are moved from the vessel through the processing chamber and a portion of the oocyst membranes are disrupted releasing sporocysts, the resulting solution is moved from the processing chamber into the delivery outlet where the solution is delivered to an animal. Methods of vaccination, including vaccination against an Eimeria infection, are also provided.

A system for delivery of a fluid to an animal is provided in the present disclosure. The system includes a reservoir to hold a volume of fluid, delivery outlet, recirculating loop, and valve in fluid communication between the reservoir and delivery outlet, the valve having an inlet to receive fluid from the reservoir, a first outlet in fluid communication with the delivery outlet, and a second outlet in fluid communication with a return conduit to the reservoir. The system further includes control means for opening and closing the first and second valve outlets, and a pump to pump fluid from the reservoir to the valve and through the reservoir return conduit to the reservoir. When the control means opens the first outlet, the fluid flows from the reservoir to the delivery outlet. When the control means opens the second valve outlet, the fluid flows through the return conduit to the reservoir.

Provided are compounds of Formula I, ##STR00001##
as well as pharmaceutical compositions containing compounds of Formula I and methods for treating Orthomyxoviridae virus infections by administering these compounds. The compounds, compositions, and methods provided are particularly useful for the treatment of Human Influenza virus infections.

To achieve stable administration of a medicine into a dermis by improving the operability of a device that inserts a microneedle into a skin. An impacting type applicator (1) for a microneedle patch is an applicator that applies a microneedle patch (3) to a skin includes a main body (5), a spring expanding/compressing lever (7), a resilient body (9), a lock mechanism (11), and a piercing switch (13). The spring expanding/compressing lever (7) is movably attached to the main body (5), and the microneedle patch (3) can be attached to a leading end of the spring expanding/compressing lever (7). The resilient body (9) is a member that imparts a biasing force to the spring expanding/compressing lever (7). The lock mechanism (11) is a mechanism that locks the spring expanding/compressing lever (7) in a state where the resilient body (9) exerts the biasing force on the main body (5). The piercing switch (13) is a member that releases the engagement between the lock mechanism (11) and the spring expanding/compressing lever (7). In addition, a biasing force imparting mechanism (121) further imparts a biasing force to the spring expanding/compressing lever (7) in a state where the spring expanding/compressing lever (7) is moved toward the leading end of the main body (5) and thereby presses the microneedle patch (3) against the skin.

An injection device comprises a housing having a proximal end, a distal end and a longitudinal axis extending therebetween. The housing has a hand grip portion with a non-rotationally symmetric cross section about the longitudinal axis of the device at the proximal end of the housing.

Described herein is a drug product delivery device and method of delivering a drug on a swab. The drug product delivery device may include an applicator platform housed within a rigid housing. The applicator platform may be in the form of a plunger. The foil drug reservoir cap creates a fluid storage chamber disposed between the foil drug reservoir cap and the plunger. A series of fluidic channels carry fluid from the fluid storage chamber to an applicator. A frangible seal is attached to the plunger between the fluid storage chamber and the applicator. The frangible seal blocks a fluid from moving from the fluid storage chamber into the series of fluidic channels. Actuation of the plunger causes the frangible seal to be ruptured, which causes the fluid to exit the fluid storage chamber and enter into the fluidic channels. The fluidic channels carry the fluid to the applicator.

An injection devices and methods of use are disclosed. The injection devices can be single use disposable injection devices. The injection devices can be pre-loaded with a medicament or be configured to receive a fluid delivery assembly within an aperture. The injection devices are also configurable to communicate with an electronic device and/or a central location.

The present invention provides for a particulate delivery device capable of facilitating both respiratory delivery of compositions under negative pressure and positive pressure. The device comprises an actuator, movable by negative pressure or positive pressure, to allow for gas flow through the device and simultaneously assist with delivery of the particulate into a vortex chamber prior to delivery to the airway of a subject.

The present invention provides for a particulate delivery device capable of facilitating both respiratory delivery of compositions under negative pressure and positive pressure. The device comprises an actuator, movable by negative pressure or positive pressure, to allow for gas flow through the device and simultaneously assist with delivery of the particulate into a vortex chamber prior to delivery to the airway of a subject.

A medicine disbursement system for maintaining a desired temperature of a liquid medication for an extended period of time before administration. The system includes a disburser having a plunger assembly surrounded by an insulation layer. An insulated medicine container is also operably used in cooperation with the disburser. A selective end to end arrangement between the disburser and the container provides a closed and insulated storage arrangement for both the medicine in the disburser and the medicine in the container. The operative connection of the dispenser and the container permits the medicine distribution system to be conveniently located for usage.